Donna R. Burgess, RPh, BCIDP

Pharmacist
UK HealthCare

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-13) Clinical Outcomes and Predictors of Mortality in AmpC-producing Gram-negative Bacteremia at a Tertiary Academic Medical Center
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-14) Unmasking the Enemy: Clinical and Microbiological Insights into P. aeruginosa Bacteremia
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-446) Clinical Characteristics and Outcomes of Pediatric Patients with Gram-negative Bacteremia at a Large Academic Medical Center
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-839) Not All Bugs Need Drugs: Leveraging ePlex Blood Culture Identification (BCID) for Smarter Stewardship
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1239) Pharmacist-Driven Beta-Lactam Therapeutic Drug Monitoring: Initial Results from In-House Pilot
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1264) The Long View: Tracking Gram-negative Susceptibility Trends from 2010-2024 to Inform Stewardship
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1265) Tracking Resistance: Four years of Pseudomonas aeruginosa and its Battle with Antibiotics
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1868) The Impact of Location and ID Consultation on Outcomes in Gram-negative Bacteremia
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1869) When Expertise Matters: ID Consultation is Associated with Lower Mortality in Serratia marcescens Bacteremia
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET